Type I gamma phosphatidylinositol phosphate kinase i5 suppresses YAP1 signaling
Journal of Biological Chemistry · 2025
DOI: 10.1016/j.jbc.2025.110573 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Biological Chemistry, 2025. Verfasst von Chinmoy Ghosh und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oral and Craniofacial Molecular Biology, Philips Institute for Oral Health Research, School of Dentistry, Virginia Commonwealth Univers…. Hauptthemen laut MEDLINE: Phosphotransferases (Alcohol Group Acceptor), Adaptor Proteins, Signal Transducing, Signal Transduction, Transcription Factors. Die Arbeit nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIDCR NIH HHS, National Institutes of Health, National Institute of Dental and Craniofacial Research.
Abstract (Originalsprache)
Dysregulation of the Hippo/Yes-associated protein (YAP) signaling pathway has been associated with several diseases, including cancer, neurological disorders, and cardiovascular conditions. However, the precise molecular mechanisms governing Hippo/YAP signaling are not fully understood, and additional regulators of this pathway need to be identified. Our research has identified type I gamma phosphatidylinositol phosphate kinase i5 (PIPKIγi5) as a regulator of Hippo/YAP signaling. PIPKIγi5 is a kinase responsible for synthesizing phosphatidylinositol-4,5-bisphosphate (PI4,5P2). By directly interacting with YAP1, PIPKIγi5 prevents the nuclear translocation of YAP1, thereby suppressing YAP1-mediated gene transcription. Thus, PIPKIγi5 functions as a suppressor of YAP1-mediated signaling. The kinase activity of PIPKIγi5, which generates PI4,5P2, is essential for controlling YAP1 function. PI4,5P2 promotes the interaction of YAP1 with the 14-3-3 protein, which retains YAP1 in the cytosol. Given the role of YAP1 signaling in cancer cell stemness, depletion of PIPKIγi5 enhances YAP1 signaling and promotes tumorsphere formation in head and neck squamous cell carcinoma. These findings highlight a PI4,5P2-modulated signaling nexus that exerts specific control over Hippo/YAP signaling and its biological functions.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Oral and Craniofacial Molecular Biology, Philips Institute for Oral Health Research, School of Dentistry, Virginia Commonwealth University, Richmond, Virginia, USA.
- Department of Oral and Craniofacial Molecular Biology, Philips Institute for Oral Health Research, School of Dentistry, Virginia Commonwealth University, Richmond, Virginia, USA; Massey Cancer Center, Virginia Commonwea…
Förderung
- NIDCR NIH HHS
- National Institutes of Health
- National Institute of Dental and Craniofacial Research
Zitieren
APA
Ghosh, C., Kakar, R., Bavuso, M., Wang, H., & Sun, Y. (2025). Type I gamma phosphatidylinositol phosphate kinase i5 suppresses YAP1 signaling. Journal of Biological Chemistry. https://doi.org/10.1016/j.jbc.2025.110573
Vancouver
Ghosh C, Kakar R, Bavuso M, Wang H, Sun Y. Type I gamma phosphatidylinositol phosphate kinase i5 suppresses YAP1 signaling. Journal of Biological Chemistry. 2025. doi:10.1016/j.jbc.2025.110573
BibTeX
@article{Ghosh2025,
author = {Ghosh, Chinmoy and Kakar, Ruchi and Bavuso, Matthew and Wang, Huizhi and Sun, Yue},
title = {Type I gamma phosphatidylinositol phosphate kinase i5 suppresses YAP1 signaling},
journal = {Journal of Biological Chemistry},
year = {2025},
doi = {10.1016/j.jbc.2025.110573}
}
EUVIMED